Fluarix™/Influsplit SSW®
Sponsors
GlaxoSmithKline
Conditions
Influenza
Phase 3
A Study for Evaluation of Immunogenicity and Reactogenicity of FluarixTM / Influsplit SSW® 2009/2010 in Adults
CompletedNCT00920374
Start: 2009-06-16End: 2009-07-08Updated: 2018-09-21
A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults
CompletedNCT01144299
Start: 2010-06-17End: 2010-07-10Updated: 2018-09-24